<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74-molecules-25-04078">
 <label>74.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ferro</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Adamska</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lattanzio</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mavrommati</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Edling</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Arifin</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Fyffe</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Sala</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sacchetto</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chiorino</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine</article-title>
  <source>Oncogene</source>
  <year>2018</year>
  <volume>37</volume>
  <fpage>6368</fpage>
  <lpage>6382</lpage>
  <pub-id pub-id-type="doi">10.1038/s41388-018-0390-1</pub-id>
  <?supplied-pmid 30061636?>
  <pub-id pub-id-type="pmid">30061636</pub-id>
 </element-citation>
</ref>
